ArticleCureus2025
Herpes Zoster Myelitis Mimicking Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying the cause of myelopathy is difficult because associated clinical and imaging findings are nonspecific. The onset pattern and magnetic resonance imaging (MRI) findings are important for the diagnosis. Herein, we present the case of a 70-year-old woman hospitalized with acute-onset weakness of the lower limbs. Blood and cerebrospinal fluid tests did not reveal any abnormalities that could have been the cause. Cerebrospinal fluid was negative for varicella-zoster virus (VZV)-DNA. Spinal cord MRI revealed an H-sign in the central gray matter of the conus medullaris, suggesting myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)-induced spinal cord inflammation. Intravenous methylprednisolone (IVMP) was initiated; however, the patient's symptoms did not improve. No anti-MOG antibodies were detected. During hospitalization, shingles appeared on the skin at the same level as the spinal cord lesions. In the repeat cerebrospinal fluid test, VZV-DNA was negative the first time, but later turned positive. We subsequently initiated treatment with acyclovir, and paralysis and bladder-rectum disorders improved. This case study provides important insights for patients with myelopathy. First, it is difficult to distinguish herpes zoster myelopathy from MOGAD because herpes zoster myelopathy presents as an H-shaped lesion in the conical area. Second, when treating myelopathy, virological confirmation via cerebrospinal fluid examination should be repeated until other diseases are diagnosed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.